[Analysis of FBN1 gene mutations in two pedigrees affected with Marfan syndrome]

Lan Yang1, Xiaoxin Guo2, Linxin Jiang3

  • 1School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, China; Department of Ophthalmology, Sichuan Provincial People's Hospital Affiliated to University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China.

Abstract

Insights

Two novel fibrillin-1 (FBN1) gene mutations, c.1879C>T and c.2584T>C, were identified in families with Marfan syndrome (MFS). These FBN1 mutations likely cause MFS by affecting protein structure and function.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Genetics

Background:

  • Marfan syndrome (MFS) is a genetic disorder affecting connective tissue.
  • Mutations in the fibrillin-1 (FBN1) gene are the primary cause of MFS.
  • Identifying specific FBN1 mutations is crucial for diagnosis and understanding disease mechanisms.

Purpose of the Study:

  • To detect mutations in the fibrillin-1 (FBN1) gene in two families with Marfan syndrome (MFS).
  • To identify novel FBN1 mutations associated with MFS in these pedigrees.

Main Methods:

  • Genomic DNA was extracted from peripheral blood samples of MFS patients and healthy relatives.
  • All 65 exons of the FBN1 gene were analyzed using next-generation sequencing.
  • Bioinformatic tools (PolyPhen-2, SIFT) were employed to predict the impact of identified mutations on FBN1 protein structure and function.

Main Results:

  • Two novel heterozygous FBN1 mutations, c.1879C>T (p.R627C) in exon 16 and c.2584T>C (p.C862R) in exon 22, were identified in MFS patients.
  • These mutations were absent in unaffected family members.
  • Bioinformatic analysis suggested that these mutations may alter the structure and function of the FBN1 protein.

Conclusions:

  • The identified FBN1 mutations, c.1879C>T and c.2584T>C, are likely responsible for Marfan syndrome in the studied pedigrees.
  • The discovery of the c.2584T>C mutation expands the known spectrum of FBN1 gene mutations associated with MFS.
  • Genetic testing for FBN1 mutations is essential for diagnosing MFS and understanding its genetic basis.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
89.0K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
63.5K
Mutations01:39

Mutations

Overview
94.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.2K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K